3D printing in drug manufacturing: unlocking future possibilities
XIL Health founder and CEO Susan Lang believes that 3D-printed drugs are poised to be the future of pharma, offering…
All articles by Kezia Parkins
Kezia Parkins
Kezia Parkins is the lead editor for Medical Device Network and Medical Technology Magazine. She is an experienced healthcare writer and editor with special interests in MedTech, clinical trials, patient centricity and global health equality.
-
-
Approach to spur testosterone production instead of synthesis on the horizon
Low testosterone in men is a widespread clinical problem linked to obesity, high blood pressure and Type 2 diabetes. Nearly…
-
Coronavirus company news summary – Moderna Covid-19 booster effective against Omicron – Everest-Providence’s vaccine gets support to join WHO STV clinical trial
Moderna has said that laboratory testing has shown that a booster shot of its Covid-19 vaccine can offer protection against…
-
Coronavirus company news summary – WHO grants emergency use approval for Novavax and SII’s Covid-19 vaccine – Switzerland orders more Covid-19 vaccine doses
The World Health Organization (WHO) has granted emergency use listing (EUL) for Novavax and Serum Institute of India’s (SII) Covid-19…
-
Coronavirus company news summary – Brazil authorises Pfizer’s Covid-19 vaccine for children – Merck’s antiviral pill for Covid-19 gains approval in Denmark
Brazilian Health Regulatory Agency Anvisa has authorised the use of Pfizer's Covid-19 vaccine in children aged between five and 11…
-
Coronavirus company news summary – Preliminary data of Sanofi-GSK Covid-19 vaccine booster shows promise – New Zealand grants provisional approval for Pfizer vaccine in children
Sanofi and GSK have reported positive preliminary booster data of their Covid-19 vaccine candidate. The companies said that a single…
-
Unmet needs: a brief history of ALS and its sparse pipeline
Few treatments are currently available for the neurodegenerative condition amyotrophic lateral sclerosis (ALS), also known as motor neurone disease and…
-
Vaxxinity CEO Mei Mei Hu on vaccine research and democratising health
Mei Mei Hu has taken an unconventional path to biotech’s upper echelons. She is the co-founder and CEO of Vaxxinity…